Parkside Financial Bank & Trust Humacyte, Inc. Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Humacyte, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 120 shares of HUMA stock, worth $151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120Holding current value
$151% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
170Shares Held
42.4MCall Options Held
548KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$8.32 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$5.81 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$3.59 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$2.69 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $130M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...